Why don’t out-of-treatment individuals enter methadone treatment programmes?

Peterson, James A.; Schwartz, Robert P.; Mitchell, Shannon Gwin; Reisinger, Heather Schacht; Kelly, Sharon M.; O’Grady, Kevin E.; Brown, Barry S.; Agar, Michael

doi:10.1016/j.drugpo.2008.07.004

Cited by 140 publications

(129 citation statements)

References 45 publications

Supporting

Mentioning

120

Contrasting

Unclassified

Order By: Relevance

“…24 Numerous other studies have confirmed the persistence of negative attitudes towards methadone and their impact on treatment recruitment and retention. 11,12,[25][26][27][28][29] Research has also shown that patients taking methadone are often hesitant to inform family members, employers, and physicians of their enrollment in treatment due to perceived stigma. 30 Such stigma and negative beliefs about methadone can lead to underutilization of a highly effective treatment modality.…”

Section: Discussionmentioning

confidence: 99%

“…Examining how buprenorphine is viewed from the user's perspective -both as a pharmacological agent and as a service delivery model -is critical for understanding the decision processes underlying their treatment selection. Based on our previous research on treatment entry and engagement, [8][9][10][11][12][13][14][15][16][17][18][19] we hypothesized that patients would choose buprenorphine treatment due to its perceived advantages over methadone in patient burden (e.g. ability to receive takehome medication more quickly, fill prescriptions at a regular pharmacy, etc.).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Patient Perspectives on Choosing Buprenorphine Over Methadone in an Urban, Equal-Access System

Gryczynski

Jaffe²,

Schwartz

et al. 2013

Am J Addict

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Patient Perspectives on Choosing Buprenorphine Over Methadone in an Urban, Equal-Access System

Gryczynski

Jaffe²,

Schwartz

et al. 2013

Am J Addict

Self Cite

View full text Add to dashboard Cite

show abstract

“…As yoga practice is a mainstream recreational activity in the United States, particularly among educated middle-class Whites (Birdee et al, 2008), their integrating postprison MBI recovery with societal reintegration will be a far less stigmatizing experience and administrative burden than what daily trips to the local methadone clinic tend to provoke (Gryczynski et al, 2011;Peterson et al, 2010). That is not to discount that regardless of race, formerly incarcerated individuals under community supervision must negotiate a host of reentry challenges.…”

Section: Mindfulness-based Interventions 1971-presentmentioning

confidence: 99%

An historical review of racial bias in prison-based substance abuse treatment design

Kerrison

2017

Journal of Offender Rehabilitation

View full text Add to dashboard Cite

This study leverages critical race and legal epidemiological frameworks to illustrate the race-based historical evolution of U.S. rehabilitation paradigms directed at imprisoned heroin and opioid users. What began as a racist early-20th-century federal antinarcotic trafficking effort has since assumed a state-based treatment agenda whose programmatic operations are largely based in correctional settings disproportionately reserved for poor substance abusers of color. Even in contemporary carceral facilities, where incarcerated populations are teeming with White addicts, in the aggregate, White drug abusers have been protected from the depraved, incorrigible, and inherently pathological drug-using caricature assigned to their non-White counterparts. This historical examination demonstrates how links between broader drug policy and prison-based drug treatment support a legally codified White supremacist narrative that erodes health and wellbeing for program participants of color, and the communities to which they inevitably return.

show abstract

“…The barriers included a long waiting list, lack of health insurance, fear of side effects of methadone, and various requirements in the registration procedure [15].…”

Section: Institutional Factorsmentioning

confidence: 99%

Factors determining dropping out from treatment among methadone clients: a qualitative study in Can Tho City, Vietnam

Hong¹,

Prisca²,

Ho³

et al. 2017

HIV & AIDS Review

View full text Add to dashboard Cite

Introduction: Methadone maintenance therapy (MMT) is a multiple therapy used for opiate dependence. It is combined with psychological therapies that aim at supporting individuals, families, and communities in improving their health, reducing criminal activities, and minimising risky behaviours for human immunodeficiency virus (HIV) transmission. Retention in treatment is associated with a successful outcome of MMT. Material and methods:Provided since 2008 in Vietnam, MMT has been implemented in Can Tho province since 2010. However, its dropout rate is high: nearly 40% from 2010 to 2015. Evidence is insufficient to understand the factors that influence the drop out rates among MMT patients in Vietnam, and more especially in Can Tho province. There is an urgent need to better understand the reasons and the context in which MMT dropouts occur, in order to inform the development of policies and programmes that can improve adherence to MMT in Can Tho.Results: Qualitative interviews have been conducted with 17 methadone clients (dropouts and current), 4 health workers and 3 family members of clients. Barriers to retention in treatment included individual factors, community factors and institutional factors. Conclusions:The factors influencing the decision to drop out among MMT clients could be at individual, community, or institutional levels. This study suggests that increasing meaningful involvement of the clients' families and strengthening counselling sessions on adherence for clients can improve their retention in treatment and thus the MMT outcomes.

show abstract

Why don’t out-of-treatment individuals enter methadone treatment programmes?

Abstract: Background-Despite the proven effectiveness of methadone treatment, the majority of heroindependent individuals are out-of-treatment.

Cited by 140 publications

References 45 publications

Patient Perspectives on Choosing Buprenorphine Over Methadone in an Urban, Equal-Access System

Patient Perspectives on Choosing Buprenorphine Over Methadone in an Urban, Equal-Access System

An historical review of racial bias in prison-based substance abuse treatment design

Factors determining dropping out from treatment among methadone clients: a qualitative study in Can Tho City, Vietnam

Contact Info

Product

Resources

About